Philip Savage

5.5k total citations
152 papers, 3.8k citations indexed

About

Philip Savage is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Philip Savage has authored 152 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Public Health, Environmental and Occupational Health, 56 papers in Pediatrics, Perinatology and Child Health and 38 papers in Oncology. Recurrent topics in Philip Savage's work include Gestational Trophoblastic Disease Studies (67 papers), Prenatal Screening and Diagnostics (51 papers) and Ectopic Pregnancy Diagnosis and Management (39 papers). Philip Savage is often cited by papers focused on Gestational Trophoblastic Disease Studies (67 papers), Prenatal Screening and Diagnostics (51 papers) and Ectopic Pregnancy Diagnosis and Management (39 papers). Philip Savage collaborates with scholars based in United Kingdom, United States and Canada. Philip Savage's co-authors include Michael J. Seckl, Neil J. Sebire, Rosemary A. Fisher, Iain Lindsay, Michael J. Seckl, Peter Schmid, D Short, Roshan Agarwal, MJ Seckl and Justin Stebbing and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Philip Savage

149 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Savage United Kingdom 36 2.1k 1.8k 689 579 498 152 3.8k
John R. Lurain United States 41 3.2k 1.5× 2.6k 1.5× 1.1k 1.5× 1.1k 1.9× 191 0.4× 176 6.4k
Nobuko Hijiya United States 33 1.6k 0.7× 1.1k 0.6× 623 0.9× 132 0.2× 156 0.3× 116 3.3k
Andrew McMillan United Kingdom 32 2.2k 1.1× 723 0.4× 2.4k 3.5× 123 0.2× 472 0.9× 117 5.5k
Line Bjørge Norway 32 340 0.2× 438 0.3× 583 0.8× 172 0.3× 764 1.5× 138 2.9k
F R Appelbaum United States 47 1.3k 0.6× 562 0.3× 2.9k 4.2× 543 0.9× 1.9k 3.9× 99 8.5k
Gritta Janka‐Schaub Germany 33 2.1k 1.0× 1.1k 0.6× 737 1.1× 579 1.0× 787 1.6× 66 5.1k
Nicolas Boissel France 42 1.9k 0.9× 466 0.3× 1.5k 2.1× 73 0.1× 1000 2.0× 200 6.1k
Brittany Harvey United States 11 989 0.5× 281 0.2× 2.5k 3.7× 302 0.5× 159 0.3× 16 4.7k
Donald Pinkel United States 34 1.9k 0.9× 1.2k 0.7× 1.1k 1.6× 325 0.6× 174 0.3× 122 4.5k
Jan Starý Czechia 42 2.4k 1.2× 931 0.5× 1.0k 1.5× 112 0.2× 445 0.9× 255 5.0k

Countries citing papers authored by Philip Savage

Since Specialization
Citations

This map shows the geographic impact of Philip Savage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Savage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Savage more than expected).

Fields of papers citing papers by Philip Savage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Savage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Savage. The network helps show where Philip Savage may publish in the future.

Co-authorship network of co-authors of Philip Savage

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Savage. A scholar is included among the top collaborators of Philip Savage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Savage. Philip Savage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xing, Eric P., et al.. (2024). 1591P Development and economic trends in new anticancer therapies licensed in the UK from 2020 to 2024. Annals of Oncology. 35. S958–S959. 1 indexed citations
2.
Simcock, Richard, et al.. (2024). NICE Technology Appraisals in Breast Oncology and the Impact on Cancer Treatment Unit Activity at the Sussex Cancer Network – 10-year Update. Clinical Oncology. 36(4). e109–e109. 2 indexed citations
3.
Venugopal, Balaji, Manon Pillai, Thomas Powles, et al.. (2021). Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes. Clinical Genitourinary Cancer. 20(1). 94–94.e10. 6 indexed citations
4.
Bergamini, Alice, Naveed Sarwar, Gabriella Ferrandina, et al.. (2020). Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis. European Journal of Cancer. 137. 136–143. 15 indexed citations
5.
Agarwal, Roshan, Philip Savage, Dee Short, et al.. (2014). Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.. PubMed. 59(1-2). 7–12. 21 indexed citations
6.
Short, Dee, et al.. (2014). Effect of early pregnancy following chemotherapy on disease relapse and fetal outcome in women treated for gestational trophoblastic neoplasia.. PubMed. 59(5-6). 248–54. 16 indexed citations
7.
You, Benoît, Richard Harvey, Émilie Hénin, et al.. (2013). Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements. British Journal of Cancer. 108(9). 1810–1816. 32 indexed citations
8.
King, Ben C., Angela Hamblin, Philip Savage, et al.. (2013). Antibody–peptide–MHC fusion conjugates target non-cognate T cells to kill tumour cells. Cancer Immunology Immunotherapy. 62(6). 1093–1105. 9 indexed citations
9.
Short, Dee, et al.. (2012). Survival of women with gestational trophoblastic neoplasia and liver metastases: is it improving?. PubMed. 57(5-6). 262–9. 25 indexed citations
10.
Sebire, Neil J., Philip Savage, Michael J. Seckl, & Rosemary A. Fisher. (2012). Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations. Placenta. 34(1). 50–56. 29 indexed citations
11.
Savage, Philip, et al.. (2010). Geochemical Implications of the Hanam Riverine Sediments during the Last 2 ka in the NW South Korea( Earth Surface Processes, Natural Disasters and Historical Environmental Changes). PubMed. 33(2). 181–196. 56 indexed citations
12.
Horlock, Claire, B. Stott, Paul J. Dyson, et al.. (2009). The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer. British Journal of Cancer. 100(7). 1061–1067. 81 indexed citations
13.
Wang, Chiuhui Mary, Peter Dixon, Matt Hodges, et al.. (2009). Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region. Journal of Medical Genetics. 46(8). 569–575. 113 indexed citations
14.
Savage, Philip. (2008). Molar pregnancy. The Obstetrician & Gynaecologist. 10(1). 3–8. 8 indexed citations
15.
Milingos, Dimitrios, et al.. (2007). Uterine arteriovenous malformation: fertility-sparing surgery using unilateral ligation of uterine artery and ovarian ligament. International Journal of Gynecological Cancer. 17(3). 735–737. 2 indexed citations
16.
Powles, T.J., Philip Savage, Justin Stebbing, et al.. (2007). A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. British Journal of Cancer. 96(5). 732–737. 78 indexed citations
17.
Morris‐Stiff, Gareth, Andrew Steel, Philip Savage, et al.. (2004). Transmission of Donor Melanoma to Multiple Organ Transplant Recipients. American Journal of Transplantation. 4(3). 444–446. 58 indexed citations
18.
Savage, Philip, Aled Clayton, Stephen Man, et al.. (2002). Anti‐viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted hla class I/peptide complexes in scid mice. International Journal of Cancer. 98(4). 561–566. 20 indexed citations
19.
Ong, Paul Jau Lueng, et al.. (2001). Tamoxifen is not detrimental to endothelial function in postmenopausal women with breast cancer. American Heart Journal. 142(4). 15A–19A. 9 indexed citations
20.
Cook, Jonathan, Philip Savage, Jonathan Lord, & Lynne M. Roberts. (1993). Biologically active interleukin 2-ricin A chain fusion proteins may require intracellular proteolytic cleavage to exhibit A cytotoxic effect. Bioconjugate Chemistry. 4(6). 440–447. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John R. Lurain Breakdown of academic impact, for papers by Nobuko Hijiya Breakdown of academic impact, for papers by Andrew McMillan Breakdown of academic impact, for papers by Line Bjørge Breakdown of academic impact, for papers by F R Appelbaum Breakdown of academic impact, for papers by Gritta Janka‐Schaub Breakdown of academic impact, for papers by Nicolas Boissel Breakdown of academic impact, for papers by Brittany Harvey Breakdown of academic impact, for papers by Donald Pinkel Breakdown of academic impact, for papers by Jan Starý
Rankless by CCL
2026